TrialSite News has profiled TriNetX, the global health research network that purports to revolutionize clinical research through the generation of real-world evidence (RWE) and its Asian expansion with the addition of 11 hospitals from Columbia Asia, an international private healthcare company. Each hospital, they report, has 100 to 200 beds offering over 40 clinical and surgical specialties covering all areas of patient care.
Who is Columbia Asia?
Founded in 1996 and based in Seattle, WA, they strive to offer quality, affordable healthcare services accessible to the community, driven by passion to provide better patient outcomes. They were founded on the premise that a growing middle class in Asia seeks out quality, accessible and modern health care facilities. According to the press release, they leverage modern technology to offer efficient specialist care and to reduce length of hospital stays resulting in more cost-effective care.
Columbia Asia, part of Seattle-based Columbia Pacific Management, ColumbiaPacificManagement.com has 29 hospitals and two clinics in India, Malaysia, Vietnam, Indonesia and Kenya, built with an innovative business model focused on serving Asia’s rapidly growing middle class with modern and efficient multi-specialty hospitals located close to where patients live and work. The company has about 10,000 employees serving more than 2.5 million patients a year, with 2,600 beds across all its facilities.
More on Facilities & Therapeutic Areas
They purport to have 29 medical facilities across Asia—12 in Malaysia, 11 in India, 3 in Vietnam and 3 in Indonesia. They have been setting up mid-sized hospitals built in residential areas for accessibility and efficiency and to better serve the respective communities. They believe that this local proximity also helps keep the costs down for patients.
They offer a wide array of medical services from General Surgery and Pediatrics to Obstetrics & Gynecology and Orthopedics to Internal medicine. They offer support via a comprehensive list of ancillary services from Intensive Care Unit, Neonatal Care Unit, Physiotherapy, Laboratory, Pharmacy and Imaging.
Columbia Asia recently raised $210 million to fuel its aggressive expansion strategy. Claiming to be one of the fastest-growing healthcare companies in Asia, they plan on having 45 hospitals and two clinics—with a total of 4,000 beds—by 2025. The most recent capital originates primarily from existing investors, including Mitsui & Co., Ltd. Other investors are primarily individuals.
Exiting out of India
Interestingly, it was recently reported in the Economic Times of India that the Seattle-based chain was in preliminary talks with investors, including Manipal Health Enterprises, Bain Capital and Temasek Holdings, to sell its Indian hospital operations for about $250-$300 million. Apparently, the leadership made a strategic decision to exit India. They have retained investment bank Morgan Stanley to run a formal M&A process.
TriNetX has partnered with healthcare organizations (HCO) spanning 24 countries and thousands of sites, and with data providers covering 99% of US health plans to deploy a linked and continually updated global health research network representing over 400 million patients. TriNetX has been used to analyze over 20,000 protocols and has presented over 5,800 clinical trial opportunities to its HCO members.
Nate McLemore, Managing Director for International Healthcare of Columbia Asia’s Parent Company Columbia Pacific Management
Rajan Narasimha Vikram, MD, General Manager, Clinical Research and Pharmacology, Columbia Asia